Aaron Roe

Senior Reseach Associate, Purification at Scribe Therapeutics

Aaron Roe has worked in a variety of roles since 2016. In 2016, they were an Nuclear Engineering and Operations Internship at IBA. In 2017, they were a Yoga Instructor at USC Events. In 2018, they were an REU Internship at CISTAR NSF Engineering Research Center. In 2019, they worked as an Undergraduate Researcher at the Bilgicer Group at the University of Notre Dame and a Process Sciences Intern at Regeneron Pharmaceuticals, Inc. In 2020, they were a Process Engineering Scientific Associate II and a Research Associate I, Process Development at Vertex Pharmaceuticals. In 2021, they were an Associate Scientist III at Ensoma. Currently, they are a Research Specialist, Purification at Scribe Therapeutics.

Aaron Roe attended Henry M Jackson High School from 2011 to 2015, where they earned a High School Diploma. Aaron then attended the University of Notre Dame from 2015 to 2020, where they earned a Bachelor of Science in Chemical and Biomolecular Engineering. Aaron is currently enrolled at Harvard Business School Online, where they are expected to receive a CORe Credential of Readiness in 2022. Aaron has also obtained a number of certifications from various institutions, including Predictive Modeling and Text Mining from SAS, Correlation and Regression from SAS, Design of Experiments from SAS, Decision Making with Data from SAS, Exploratory Data Analysis from SAS, Statistical Thinking and Problem Solving from SAS, Managing Process Safety Hazards from AIChE - American Institute of Chemical Engineers, Process Safety from AIChE - American Institute of Chemical Engineers, Toxicological Hazards from AIChE - American Institute of Chemical Engineers, RYS 200 Yinyasa Yoga Teacher Certification from Yoga Alliance, Radiological Worker Certification from IBA, and Adult First Aid/CPR/AED from ProTrainings.

Links

Previous companies

Vertex Pharmaceuticals logo
University of Notre Dame logo

Timeline

  • Senior Reseach Associate, Purification

    September, 2022 - present

View in org chart